| |
|
|
|
|
|
|
|
|
1. |
Record Nr. |
UNISA990000228100203316 |
|
|
Autore |
Ben_Ari, M. |
|
|
Titolo |
Principles of concurrent and distributed programming / M. Ben-Ari |
|
|
|
|
|
Pubbl/distr/stampa |
|
|
New York [etc.] : Prentice Hall, copyr. 1990 |
|
|
|
|
|
|
|
ISBN |
|
|
|
|
|
|
Descrizione fisica |
|
|
|
|
|
|
Collana |
|
Prentice Hall international seriesin computer science ; 0 |
|
|
|
|
|
|
Disciplina |
|
|
|
|
|
|
Collocazione |
|
|
|
|
|
|
Lingua di pubblicazione |
|
|
|
|
|
|
Formato |
Materiale a stampa |
|
|
|
|
|
Livello bibliografico |
Monografia |
|
|
|
|
|
2. |
Record Nr. |
UNINA9910830340303321 |
|
|
Autore |
Eichstadt Forsythe Lauren R. |
|
|
Titolo |
Drug compounding for veterinary professionals / / Lauren R. Eichstadt Forsythe, Alexandria E. Gochenauer |
|
|
|
|
|
|
|
Pubbl/distr/stampa |
|
|
Hoboken, NJ : , : John Wiley & Sons, Inc., , [2023] |
|
©2023 |
|
|
|
|
|
|
|
|
|
ISBN |
|
1-119-76499-8 |
1-119-76497-1 |
|
|
|
|
|
|
|
|
Descrizione fisica |
|
1 online resource (174 pages) |
|
|
|
|
|
|
Disciplina |
|
|
|
|
|
|
Soggetti |
|
|
|
|
|
|
Lingua di pubblicazione |
|
|
|
|
|
|
Formato |
Materiale a stampa |
|
|
|
|
|
Livello bibliografico |
Monografia |
|
|
|
|
|
Nota di bibliografia |
|
Includes bibliographical references and index. |
|
|
|
|
|
|
Nota di contenuto |
|
Cover -- Title Page -- Copyright Page -- Contents -- Foreword -- Preface -- List of Acronyms -- About the Companion Website -- |
|
|
|
|
|
|
|
|
|
Introduction -- Chapter 1 Compounding Regulations -- Organizations and Regulatory Agencies Involved with Compounding -- Food and Drug Administration -- United States Pharmacopeia -- Drug Enforcement Administration -- State Boards of Pharmacy -- State Veterinary Boards -- Compliance Policy Guides and Guidance for Industry Documents -- What Is Compounding? -- The Food, Drug, and Cosmetic Act -- Animal Medicinal Drug Use Clarification Act -- Preparing Compounds from an Approved Product or a Pure Drug Powder -- Federal Versus State Law [8] -- Office Use Compounding -- Drug Quality and Security Act [26] -- Finding Additional Information -- References -- Chapter 2 Risk-Benefit Analysis of Compounded Medications -- Benefits of Compounded Products -- Dosage Form -- Flavoring -- Dosage Strength -- Eliminating Ingredients -- Availability Issues -- Appropriate Use of Compounded Medications -- FDA-Approved Drugs -- Compounded Medication Risks -- Compounded (USP) Versus Manufactured (cGMP) -- Risks Associated with Compounded Medications - A Look at the Literature -- Studies Showing Incorrect Potency -- Studies Showing Lack of Stability -- Studies Showing Lack of Efficacy -- Risks Associated with Specific Types of Compounds -- Active Ingredient Source Decisions -- Patient-Specific Compounding Versus Office Use Compounding -- Adverse Event Reporting -- Identifying Potential Formulation Issues -- Drugs Recalls -- Selecting a Compounding Pharmacy -- Client Education -- Reducing Risk in Practice -- Conclusion -- References -- Chapter 3 Beyond-Use Dating -- Factors Considered When Assigning BUDs and Expiration Dates -- USP Default BUDs -- Stability Studies -- Evaluating Stability Studies -- Determining BUDs for In-House Formulations. |
BUD Considerations When Prescribing Compounded Medications -- Conclusion -- References -- Chapter 4 Identifying High-Quality Compounding Pharmacies -- Case Study 1 -- Case Study 2 -- What to Evaluate -- General Practices -- Staff Skill Level -- Familiarity with Veterinary Medicine -- Pharmacy Culture -- Ways to Evaluate Compounding Pharmacies -- Looking Beyond the Pharmacy's Website -- What to Look for on a Tour -- Questions to Ask the Pharmacist in Charge -- Conclusion -- References -- Chapter 5 Formulation Development -- Dosage Forms -- Oral Administration -- Transdermal Administration -- Topical Administration -- Otic Administration -- Other Routes of Administration -- Ingredients -- Organic Salts -- Inorganic Salts -- Oral Liquid Medications -- Oral Solid Medications -- Emulsions -- Transdermal Medications -- Cream, Gel, and Ointment Medications -- Hazardous Drugs -- Beyond-Use Dates -- Formulation Resources -- Calculations -- Measurements Used in Compounding -- Displacement Factor -- Capsules: Packing Statistics -- Packing Statistic of Drug -- Average Weight of Ingredients -- Percentage of Drug per Capsule Using Bulk Powder -- Percentage of Drug per Capsule Using Manufactured Tablet -- Percentage/Amount of Filler per Capsule -- Conversion to Grams -- Compounding Formulations to Avoid -- Formulation Development Process -- Developing a Compounding Formula: Example 1 (USP Compounding Compendium) -- Developing a Compounding Formula: Example 2 (Stability-Indicating Assay) -- Compounding Formulation Assessment -- References -- Chapter 6 Compounding in House -- Documentation -- Master Formulation Record -- Compounding Record -- Formulation Record Components -- Quality Assurance and Quality Control -- Labeling -- Packaging and Storage -- Compounding Techniques -- Trituration -- Sifting -- Geometric Dilution -- Wetting -- Colored Tracers -- Equipment. |
Mortars and Pestles -- Glassware -- Containers -- Scales -- Spatulas and Measuring Devices -- Equipment Cleaning -- Training -- |
|
|
|
|
|
|
|
|
|
|
|
Formulation Instructions -- Species-Specific Information -- Flavoring -- Toxicities -- Potency Designations -- Feasibility for a Veterinary Clinic -- References -- Index -- EULA. |
|
|
|
|
|
|
3. |
Record Nr. |
UNISA996211260203316 |
|
|
Titolo |
15th Annual IEEE ASIC Conference and Exhibit |
|
|
|
|
|
Pubbl/distr/stampa |
|
|
[Place of publication not identified], : IEEE, 2002 |
|
|
|
|
|
|
|
Descrizione fisica |
|
1 online resource : illustrations |
|
|
|
|
|
|
Disciplina |
|
|
|
|
|
|
Soggetti |
|
|
|
|
|
|
Lingua di pubblicazione |
|
|
|
|
|
|
Formato |
Materiale a stampa |
|
|
|
|
|
Livello bibliografico |
Monografia |
|
|
|
|
|
Note generali |
|
Bibliographic Level Mode of Issuance: Monograph |
|
|
|
|
|
|
Nota di bibliografia |
|
Includes bibliographical references and index. |
|
|
|
|
|
| |